Results 201 to 210 of about 85,956 (353)
Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54
N. de Roux+5 more
semanticscholar +1 more source
ABSTRACT Background The United States Food and Drug Administration (FDA) approved oral finasteride for androgenetic alopecia. In 2022, approximately 2.6 million U.S. men used it for hair loss and prostate conditions. Post‐finasteride syndrome (PFS), proposed in 2012, involves persistent sexual and neuropsychiatric adverse events (AEs) after cessation ...
Aditya K. Gupta+3 more
wiley +1 more source
ABSTRACT Objectives We aimed to identify clinical predictors of response to testosterone replacement therapy in boys with micropenis, focusing on initial penile measurements, hormone levels, and treatment timing relative to the mini‐puberty period.
Junki Harada+16 more
wiley +1 more source
Treatment of Delayed Puberty and Hypogonadism in Girls [PDF]
Claudine Heinrichs, J P Bourguignon
openalex +1 more source
Age is significantly associated with hypergonadotropic hypogonadism, while insulin resistance and visceral adiposity are strongly linked to hypogonadotropic hypogonadism. Older and obese Malaysian type 2 diabetes mellitus males, particularly those with coronary artery disease and lower HDL‐C levels, are at higher risk.
Waye‐Hann Kang+2 more
wiley +1 more source
Background Human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) is an endemic chronic disease which is characterized with progressive depletion of CD4 T cells and increased susceptibility to opportunistic infections.
Shabani Iddi+3 more
doaj +1 more source